Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115636829B reveals efficient rhodium catalysis for luminescent materials. Offers scalable production and cost advantages for electronic chemical manufacturing supply chains.
Patent CN118619879A reveals a novel Rh-catalyzed route for trifluoromethyl enaminones, offering high purity and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN115215814A details a robust Rh-catalyzed route to isoxazolidines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel cobalt-catalyzed carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. Cost-effective, scalable route for pharmaceutical intermediates.
Novel rhodium-catalyzed route for high-purity indole intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing processes globally.
Patent CN118619879A details rhodium-catalyzed synthesis improving supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel rhodium-catalyzed synthesis of anticancer succinimide spiro-sultams offers high efficiency and broad substrate scope for pharmaceutical intermediate manufacturing.
Patent CN115636829B reveals a high-yield Rhodium-catalyzed route for trifluoromethyl benzo[1,8]naphthyridine, offering cost-effective supply for organic luminescent materials.
Novel C-H activation method for 2-(3-isoquinolyl)-propionic acid esters. Efficient, mild conditions, high atom economy for API manufacturing.
Efficient cobalt-catalyzed C-H activation for indole carboxamides. Reduces cost and improves supply chain reliability for pharma intermediates.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Patent CN102256981A details a novel route for Anagrelide avoiding toxic nitriles and tin waste, offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Patent CN117417339A details Rhodium-catalyzed synthesis offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
Novel rhodium-catalyzed method enables scalable, high-purity trifluoromethyl indole synthesis with simplified purification and cost reduction in pharmaceutical manufacturing.
Patent CN115260188B enables scalable, cobalt-catalyzed synthesis of tetrahydro-beta-carboline ketones with high substrate tolerance and simplified purification, offering supply chain resilience for pharmaceutical intermediates.
Novel rhodium-catalyzed method enables scalable, cost-efficient production of high-purity trifluoromethyl indoles with broad functional group tolerance.
Novel cobalt-catalyzed synthesis enables scalable production of tetrahydro-beta-carbolinone intermediates with enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN118619879A introduces rhodium-catalyzed synthesis enabling high-purity trifluoromethyl enaminones with simplified scale-up and enhanced supply chain reliability.
Novel Pd-catalyzed method enables atom-economical lactam synthesis using air as oxidant with enhanced purity and supply chain reliability for pharmaceutical manufacturing.